Komori
Ishihara Chemical (4462) · PolicyAdvanced

Verification of the Rationale for Holding Strategic Shareholdings and Maintaining and Strengthening Business Relationships

First written in FY2019. 14 of 15 entries say "Advanced", first in FY2020. Latest entry: FY2026.

15entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020 – FY20262019: 120192020: 120202021: 320212022: 120222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
Verification of the Rationale for Strategic ShareholdingsA theme 1242 companies write about · 1 as a headwind · 661 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1246 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Shares other than unlisted shares 3 266,040」

    With respect to policy-held shares, the company sold 3 issues during the fiscal year and disclosed total sale proceeds of ¥266.04 million. It also recorded a ¥160.056 million gain on the sale of investment securities, indicating that sales in line with its policy of reducing holdings have continued.
  2. FY2026-H1AdvancedAnnual report

    「Gain on sale of investment securities 104,832」

    The company recorded a ¥105 million gain on the sale of investment securities during the interim consolidated accounting period, indicating that it reduced its holdings through sales of investment securities. This disclosure does not expressly state that the shares sold were policy-held shares.
  3. FY2025AdvancedAnnual report

    「Shares other than unlisted shares 2 68,600」

    During the fiscal year, the company sold 2 issues of shares other than unlisted shares, including policy-held shares, and disclosed total sale proceeds of ¥68.6 million. It continues to sell shares in line with its policy of reducing holdings.
  4. FY2025-H1AdvancedAnnual report

    「The main changes were a ¥854 million decrease in investment securities, a ¥108 million increase in property, plant and equipment, and a ¥31 million increase in life insurance reserve assets, among others.」

    The balance of investment securities decreased by ¥854 million, indicating that the trend of reducing holdings of cross-shareholdings and other policy-held shares has continued. This interim report does not expressly state that the decrease relates to policy-held shares.
  5. FY2024-Q3AdvancedAnnual report

    「Gain on sales of investment securities 167,204」

    The company recorded a gain on sales of investment securities of ¥167,204 thousand for the cumulative third quarter, indicating that holdings were reduced through the sale of cross-shareholdings and other investments.
  6. FY2024-Q2AdvancedAnnual report

    「Gain on sales of investment securities 131,492」

    The company recorded a gain on sales of investment securities of ¥131,492 thousand for the cumulative second quarter, while the balance of investment securities also decreased by ¥212 million. This disclosure does not explicitly state that the assets sold were cross-shareholdings, but indicates that holdings were sold and the balance was reduced.
  7. FY2024-Q1AdvancedAnnual report

    「Gain on sales of investment securities ― 65,886」

    The company recorded a gain on sales of investment securities of ¥65,886 thousand, indicating that holdings were reduced through the sale of cross-shareholdings and other investments. However, this disclosure does not explicitly state that the assets sold were cross-shareholdings.
  8. FY2023AdvancedAnnual report

    「Shares other than non-listed shares 4 190,278」

    For cross-shareholdings, the company disclosed the sale during the fiscal year of 4 holdings other than non-listed shares, with total sale proceeds of ¥190,278 thousand. It also described reducing or selling all shares of individual holdings deemed to have insufficient significance.
  9. FY2023-Q3AdvancedAnnual report

    「The balance of property, plant and equipment decreased by ¥1,005 million from the end of the previous consolidated fiscal year to ¥12,997 million. The main change was a ¥984 million decrease in investment securities, among other factors.」

    The balance of investment securities decreased by ¥984 million from the end of the previous consolidated fiscal year. This disclosure does not explicitly identify the investment securities that decreased as individual cross-shareholdings, but indicates a reduction in the balance of holdings.
  10. FY2023-Q2AdvancedAnnual report

    「This was due mainly to a ¥402 million decrease in investment securities.」

    The balance of investment securities decreased by ¥402 million from the end of the previous consolidated fiscal year, and a gain on sales of investment securities of ¥4,245 thousand was also recorded for the cumulative second quarter. The reduction in the balance suggests a connection with the policy of reducing cross-shareholdings, but this disclosure does not explicitly identify the individual securities as cross-shareholdings.
  11. FY2022-Q2AdvancedAnnual report

    「Gain on sales of investment securities 183,076」

    The company recorded a gain on sales of investment securities of ¥183,076 thousand for the cumulative second quarter, confirming that holdings were reduced through the sale of cross-shareholdings and other investments. The balance of investment securities also decreased by ¥526 million from the end of the previous fiscal year.
  12. FY2021AdvancedAnnual report

    「For each cross-shareholding, the company determines at each fiscal year-end whether continued ownership is appropriate, taking into account the significance of the holding and its medium- to long-term economic rationale. For the cross-shareholdings held at the end of the current fiscal year, the Board of Directors resolved at its meeting held on 28 April 2021 to sell part of the holdings.」

    For cross-shareholdings, the Board of Directors resolved to sell part of the holdings, and during the fiscal year sold 5 holdings other than non-listed shares. The total sale value was ¥278,414 thousand.
  13. FY2021-Q3AdvancedAnnual report

    「Net income attributable to owners of the parent was ¥1,007 million, up 27.8% year on year, due in part to gains on sales of investment securities from the sale of cross-shareholdings.」

    The disclosure states that gains were recorded on the sale of cross-shareholdings, confirming that sales were carried out in connection with the policy of reducing cross-shareholdings.
  14. FY2020AdvancedAnnual report

    「The company states that, in principle, it intends to reduce its cross-shareholdings.」

    The company explicitly stated its policy of reducing cross-shareholdings. The Board of Directors resolved at its meeting held on 28 April 2020 to sell part of the holdings, and during the fiscal year sold 2 non-listed holdings.
  15. FY2019First statedAnnual report

    「The company does not hold shares for pure investment purposes and holds only cross-shareholdings that also serve important management-strategy purposes other than pure investment, such as strengthening relationships through business alliances. In this context, to achieve sustainable growth and enhance corporate value over the medium to long term, the company may hold shares in companies when it deems them necessary as part of its business strategy, including business alliances, or to maintain and strengthen business relationships.」

    The disclosure describes, for the first time as a standalone topic, the policy of holding cross-shareholdings for business alliances and to maintain and strengthen business relationships, and reviewing the significance and medium- to long-term economic rationale of the holdings at each fiscal year-end.
Moved together

"Business expansion through the development of new products, technologies and markets" moved the same way as this thread, in the same document, in 14 of its 15 moves.

141312987★123456
  1. ★This thread
  2. 1Business expansion through the development of new products, technologies and markets14×
  3. 2Priority Allocation of Retained Earnings to Research and Development, New Businesses and New Technologies13×
  4. 3Diversification of Production Locations and Expansion of Production Capacity12×
  5. 4Strengthening Shareholder Returns Based on Stable Dividends9×
  6. 5Risk of Price Declines and Market Volatility Relating to Securities Held8×
  7. 6Enhancing corporate value by improving ordinary profit, ROE and EPS7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ishihara Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Verification of the Rationale for Holding Strategic Shareholdings and Maintaining and Strengthening Business Relationships | ISHIHARA CHEMICAL CO.,LTD. (4462) | Komori